Investigating the Effectiveness of e-CBTi Compared to Pharmaceutical Interventions in Treating Insomnia
Status:
Recruiting
Trial end date:
2023-01-30
Target enrollment:
Participant gender:
Summary
Insomnia is defined as the inability to fall asleep or stay asleep at night and it is one of
the most prevalent sleep disorders that can have deleterious impacts on health and this
population's quality of life. Currently, both pharmaceutical interventions (trazodone) and
cognitive behavioral therapy (CBTi) are widely used to treat patients with insomnia. Although
CBTi has been efficacious in many patients, multitude of barriers for receiving treatment
such as its limited availability of therapists, high costs and long wait times challenge its
ability in sufficiently meeting the population's health needs and demands. To improve the
delivery of CBT, electronically delivered CBTi (e-CBTi) has been developed as an accessible
and effective alternative intervention for improving sleep outcomes in patients with
insomnia. While evidence suggest that e-CBTi is effective when compared to placebos/waitlist
control, evidence comparing guided e-CBTi to pharmaceutical interventions is still
insufficient and needs further exploration.